Global /United States /Healthcare /Drug Manufacturers - Specialty & Generic /FFNT
chevron_leftBack
4Front Ventures Corp. logo

4Front Ventures Corp.

FFNT
CSE: FFNT Delayed
0.0050CAD 0%
0.0036 USD
As of 14 June 2026, 4Front Ventures Corp. has a market cap of $3.28M USD, ranking #45894 globally and #5825 in the United States. It ranks #4066 in the Healthcare sector, and #297 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
45894
Country Rank
5825
Sector Rank
4066
Industry Rank
297
Key Stats
Market Cap
$3.28MUSD
4.58M CAD
Enterprise Value
$224.33MUSD
313.96M CAD
Revenue (TTM)
$73.07MUSD
102.14M CAD
EBITDA (TTM)
-$16.44MUSD
-23.01M CAD
Net Income (TTM)
-$35.18MUSD
-49.18M CAD
EBITDA Margin
-23%
Profit Margin
-48%
PS Ratio
0.0
PB Ratio
-0.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Andrew Thut open_in_new
Employees
399
Founded
2011
Website
4frontventures.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% 0% -50% -75% -90% -96%

News

Loading...

Markets

Exchange Ticker Price
Canadian Securities Exchange
MIC: XCNQ
PRIMARY
FFNT
4Front Ventures Corp
ISIN: CA35086B2075
Shares Out.:
913.929M1 Shares Float: 312.622M2
TV:
SA:
YF:
GF:
BA:
MS:
0.0050 CAD
Cboe Canada
MIC: NEOE
FFNT
4Front Ventures Corp
ISIN: CA35086B2075
TV:
SA:
YF:
GF:
BA:
MS:
0.0100 CAD
OTC Markets
MIC: OTCM
FFNTF
4Front Ventures Corp
ISIN: CA35086B2075
TV:
SA:
YF:
GF:
BA:
MS:
0.0009 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About 4Front Ventures Corp.

4Front Ventures Corp. engages in cultivating, processing, manufacturing, and sale of cannabis products in the United States. The company operates through three segments: Illinois, Massachusetts, and Corporate. It offers flower, pre-rolls, vaporizers, concentrates, edibles, tinctures and soft gels, capsules, and topicals, as well as provides a vertically integrated supply chain to serve both medical and recreational markets. The company owns, operates, and manages cultivation and manufacturing facilities and retail centers; sales CBD products to third-party consumers; leases real estate in the state of Washington; and engages in other corporate activities. 4Front Ventures Corp. was founded in 2011 and is based in Phoenix, Arizona.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (United States)
Name
Market Cap diff.
PE
$29.56B
902K%
-
INDV
$2.07B
1.54B GBP
63K%
-
NDOI
$1.8B
55K%
0.4
$1.76B
54K%
-
$1.33B
40K%
-
$1.02B
31K%
12.1
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$36.75B
108.92B ILS
1M%
24.2
$15.84B
107.34B CNY
483K%
16.0
CIPLA
$11.16B
1.06T INR
340K%
23.4
LUPIN
$11.04B
1.05T INR
337K%
22.7
$9.09B
61.6B CNY
277K%
80.6
$8.74B
7.57B EUR
267K%
-
chevron_leftBack